Development of Novel Immunotherapies for Multiple Myeloma

Multiple myeloma (MM) is a disorder of terminally differentiated plasma cells characterized by clonal expansion in the bone marrow (BM). It is the second-most common hematologic malignancy. Despite significant advances in therapeutic strategies, MM remains a predominantly incurable disease emphasizi...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hujaily, Ensaf M., Oldham, Robyn A. A., Hari, Parameswaran, Medin, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037783/
https://www.ncbi.nlm.nih.gov/pubmed/27618026
http://dx.doi.org/10.3390/ijms17091506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037783/
https://www.ncbi.nlm.nih.gov/pubmed/27618026
http://dx.doi.org/10.3390/ijms17091506

Ejemplares similares